A 35-year-old man with community-acquired pneumonia due to E. coli (isolated from blood culture) presents with fever, cough, and hypoxia. Sputum culture and blood culture both grow E. coli susceptible to all beta-lactams, fluoroquinolones, and aminoglycosides. What is the drug of choice for E. coli bacteremia with pneumonia?

Explanation

## Drug of Choice for E. coli Bacteremia and Pneumonia ### Third-Generation Cephalosporin as First-Line **Key Point:** Third-generation cephalosporins (cefotaxime, ceftriaxone) are the preferred empiric and definitive agents for E. coli bacteremia and community-acquired pneumonia (CAP). **High-Yield:** Cephalosporins provide excellent lung penetration, rapid bactericidal activity, and broad gram-negative coverage — essential for systemic infection with documented bacteremia. ### Why Cephalosporins for Bacteremia? | Feature | Cefotaxime / Ceftriaxone | Fluoroquinolone | Aminoglycoside | Amoxicillin-clavulanate | | --- | --- | --- | --- | --- | | **Bacteremia indication** | ✓ Yes (first-line) | No (oral/IV, but not first-line) | No (adjunct only) | No (inadequate for systemic) | | **Lung penetration** | Excellent | Good | Poor | Moderate | | **Bactericidal activity** | Rapid, concentration-dependent | Rapid, time-dependent | Rapid, concentration-dependent | Moderate | | **Oral bioavailability** | No (IV/IM only) | Yes (oral option) | No (IV/IM only) | Yes (oral option) | | **CNS penetration** | Good (meningitis-level dosing) | Excellent | Poor | Poor | | **Monotherapy adequacy** | ✓ Yes | ✓ Yes (if susceptible) | ✗ No (requires beta-lactam) | ✗ No (inadequate for bacteremia) | **Clinical Pearl:** Bacteremia mandates parenteral therapy with a beta-lactam (cephalosporin or carbapenem). Fluoroquinolones are acceptable alternatives in penicillin-allergic patients, but cephalosporins remain preferred for their superior bactericidal kinetics and lung penetration in pneumonia. **Mnemonic:** **CEPHA-BACTER** — **CEPHA**losporin for **BACTER**emia (systemic E. coli infection). ### Dosing for Pneumonia with Bacteremia - **Cefotaxime:** 1–2 g IV every 4–6 hours - **Ceftriaxone:** 1–2 g IV every 12 hours - Duration: 7–10 days for CAP (longer if complications) **Warning:** Do NOT use aminoglycosides (gentamicin) as monotherapy for gram-negative bacteremia — they are bactericidal but require combination with a beta-lactam for synergy and are inadequate as sole agents for systemic infection.